FDA Approves Second Gene Therapy for Hemophilia B
Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
Source: medscape.com
Stay updated with breaking news from Olt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The
ESO, European Organisation for Astronomical Research in the Southern Hemisphere
Quilter plc (QLT.LON): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Quilter plc | London S.E.: QLT | London S.E.
No one knows – nearly 80 years after a World War II soldier and the mononymous ‘Jessie’ exchanged letters, she remains just that. A Christian name in a war...